RELEASE: September 25, 2026 (Recorded: January 8, 2026)
EXPIRATION: March 30, 2029

SPEAKER: Sumanta Pal, MD, FASCA 

INSTRUCTIONS

• Scroll to the bottom of the page and click "Please login".  Once you have done so, it will return you to this page.
• Scroll down to the bottom of the page and click the Start button.
• Participate in the quiz.  Participants must pass by a minimum of 80%, 1 re-take is allowed.  Quizzes have between 2-5 questions.
• Click through to the end to ensure credits post to your transcript.

LEARNING OBJECTIVES
Upon conclusion of this activity, participants should be able to:

• Summarize different treatments for RCC 

• Demonstrate the role of Microbiome in RCC 

• Identify patients for clinical trials 

COURSE DIRECTOR
Rami Manochakian, M.D.

DESCRIPTION 
This online course convenes experts, innovators, and thought leaders to deliver cancer-related content. Its goal is to enhance and develop specialized education and training programs for Mayo Clinic nursing staff, focusing on cancer prevention, care, and long-term follow-up. These programs apply to hematology, oncology, and other cancer-related specialties. 

TARGET AUDIENCE
This course is intended for nurses and nurse practitioners in the hematology, oncology, and other cancer-related specialties.  

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

CREDIT STATEMENT(S)
ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 0.75 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities. All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.  Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance. 

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
Audrey Elegbede, Ph.D., M.A. - New Business Venture - Ele-Ile LLC
Vinicius Ernani, M.D. - Honoraria - AstraZeneca Pharmaceuticals LP; BioAlta; Daiichi Sankya, Inc.; Johnson and Johnson; Nuvation Bio 
Rami Manochakian, M.D. - Honoraria - AbbVie, Inc.; Amgen, Inc.; AstraZeneca Pharmaceuticals LP; BMS Global, Inc.; Bristol-Myers Squibb Company; Cardinal Health, Inc.; Daiichi Sankyo, Inc.; Janssen Scientific Affairs, LLC; Novocure Inc.
Brittany Siontis, M.D. - Honoraria - Deciphera Pharmaceuticals; and Ratio Therapeutics

SPEAKER: 
Sumanta Pal, MD, FASCA - Consultant - Travel support: Ipsen, CRISPR
Sumanta Pal, MD, FASCA - Grant/Research Support - Exelixis, Merck, Osel, Genentech, Adicet Bio, ArsenalBio, Xencor, Miyarsian Pharmaceutical 

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
Miriam Hobbs, APRN, C.N.P., D.N.P.
Corinne Irish
Michelle Cooper (Coordinator)

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.

Disclaimer
Participation in this Mayo Clinic educational activity does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course. You should be aware that substantive developments in the medical field covered by this recording may have occurred since the date of original release.

Prospective attendees, please note that the content for this online activity has been repurposed from the Mayo Clinic Comprehensive Cancer Center Enterprise Grand Rounds. If you attended the live activity, you have already received credit for these educational sessions. 

Prerequisites for Participation
There are no prerequisites needed prior to participating in this education activity.

Method of Participation
Participation in this activity consists of reviewing the educational material, completing the learner assessment and evaluation.

How to Obtain Credit
To obtain credit, complete the assessment, evaluation and submit.

Acknowledgement of Commercial Support
No commercial support was received in the production of this activity. 

Bibliographic Resources 
Overholser, L., & Callaway, C. (2019, May 1). Improving Care Coordination to Optimize Health Outcomes in Cancer Survivors. Journal of the National Comprehensive Cancer Network, 17 (5.5), 607-610. doi:10.6004/jnccn.2019.5009 
Bioinformatics, Big Data, and cancer. National Cancer Institute. (n.d.). Retrieved January 12, 2023, from https://www.cancer.gov/research/infrastructure/bioinformatics 

Copyright 
Mayo Foundation for Medical Education and Research. All rights reserved. Copyright 2026 

TRANSCRIPT
Any credit or attendance awarded will appear on your Transcript.

QUESTIONS?
Contact Corinne Irish